1134-8046

S1134-80462022000200005

10.20986/resed.2022.4027/2022

España

00 00 2022

29 20 26

2013 20 3 3

132-6

2021 28 3 3

2021 162 Suppl 1 Suppl 1

S67-79

2008 9 6 6

506-21

2018 91 14 14

e1285-94

2017 78 5-6 5-6

320-9

2017 125 5 5

1638-52

2018 159 10 10

1932-54

Committee for Medicinal Products for Human Use 2007

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research 2014

2019 160 6 6

1235-9

2021 162 Suppl 1 Suppl 1

S45-66

2022 26 6 6

1183-5

2017 358

2018 22 9 9

1547-64

2018 64 2 2

111-20

2018 5 3 3

2022 7 4 4

482-500

2021 162 Suppl 1 Suppl 1

S105-9

2021 25 2 2

359-74

2022 26 2 2

480-91

2022 36 1 1

31-44

2021 10 16 16

IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia

2021 162 Suppl 1 Suppl 1

S1-2